135 related articles for article (PubMed ID: 23951904)
21. Probiotic therapy: a real tool to reduce intestinal infections?
Nava GM; Davila V
Med Sci Monit; 2004 Nov; 10(11):LE22-3. PubMed ID: 15507860
[No Abstract] [Full Text] [Related]
22. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome.
Kajander K; Krogius-Kurikka L; Rinttilä T; Karjalainen H; Palva A; Korpela R
Aliment Pharmacol Ther; 2007 Aug; 26(3):463-73. PubMed ID: 17635381
[TBL] [Abstract][Full Text] [Related]
23. [Probiotics in gastrointestinal disorders].
Lakatos G; Tulassay Z
Orv Hetil; 2009 May; 150(19):883-94. PubMed ID: 19403432
[TBL] [Abstract][Full Text] [Related]
24. [Probiotic using as a part of complex therapy of disbiotic violations at some intestinal diseases].
Gurevich KG; Nikonov EL; Zaborova VA; Shelekhova TY; Zolnikova OY
Vopr Pitan; 2019; 88(1):77-84. PubMed ID: 30811137
[TBL] [Abstract][Full Text] [Related]
25. [INFLUENCE OF PROBIOTIC STRAIN E. FAECIUM L3 ON MYOCARDIAL TOLERANCE TO ISCHEMIA-REPERFUSION INJURY IN THE MODEL OF ANTIBIOTIC-INDUCED INTESTINAL DYSBIOSIS].
Borshcev YY; Minasian SM; Burovenko IY; Ermolenko EI; Suvorov AN; Galagudza MM
Ross Fiziol Zh Im I M Sechenova; 2016 Nov; 102(11):1323-32. PubMed ID: 30193448
[TBL] [Abstract][Full Text] [Related]
26. [The role of small bowel microflora in the development of secondary lactase deficiency and the possibilities of its treatment with probiotics].
Ruchkina IN; Fadeeva NA; Parfenov AI; Shcherbakov PL; Gubina AV; Poleva NI; Khomeriki SG; Chikunova BZ
Ter Arkh; 2013; 85(2):21-6. PubMed ID: 23653934
[TBL] [Abstract][Full Text] [Related]
27. Modulation of virulence and antibiotic susceptibility of enteropathogenic Escherichia coli strains by Enterococcus faecium probiotic strain culture fractions.
Ditu LM; Chifiriuc MC; Bezirtzoglou E; Voltsi C; Bleotu C; Pelinescu D; Mihaescu G; Lazar V
Anaerobe; 2011 Dec; 17(6):448-51. PubMed ID: 21723403
[TBL] [Abstract][Full Text] [Related]
28. [Use of enterosorbent in the treatment of intestinal dysbiosis].
Shcherbakov PL
Eksp Klin Gastroenterol; 2009; (3):88-92. PubMed ID: 19928005
[TBL] [Abstract][Full Text] [Related]
29. Molecular and probiotic characterization of bacteriocin-producing Enterococcus faecium strains isolated from nonfermented animal foods.
Hosseini SV; Arlindo S; Böhme K; Fernández-No C; Calo-Mata P; Barros-Velázquez J
J Appl Microbiol; 2009 Oct; 107(4):1392-403. PubMed ID: 19426265
[TBL] [Abstract][Full Text] [Related]
30. [Prevention of intestinal dysbiosis in patients after anti-Helicobacter therapy].
Masharova AA; Eremina EIu
Eksp Klin Gastroenterol; 2009; (8):108-11. PubMed ID: 20469687
[TBL] [Abstract][Full Text] [Related]
31. Clinical efficacy of probiotics: review of the evidence with focus on children.
; Michail S; Sylvester F; Fuchs G; Issenman R
J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):550-7. PubMed ID: 17033538
[TBL] [Abstract][Full Text] [Related]
32. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study.
Mego M; Koncekova R; Mikuskova E; Drgona L; Ebringer L; Demitrovicova L; Nemova I; Trupl J; Mardiak J; Koza I; Zajac V
Support Care Cancer; 2006 Mar; 14(3):285-90. PubMed ID: 16175356
[TBL] [Abstract][Full Text] [Related]
33. The effect of the probiotic strain Enterococcus faecium DSM 7134 in combination with natural humic substances on performance and health of broiler chickens.
Demeterová M; Mariscáková R; Pistl J; Nad P; Samudovská A
Berl Munch Tierarztl Wochenschr; 2009; 122(9-10):370-7. PubMed ID: 19863009
[TBL] [Abstract][Full Text] [Related]
34. Clinical studies on alleviating the symptoms of irritable bowel syndrome.
Kajander K; Korpela R
Asia Pac J Clin Nutr; 2006; 15(4):576-80. PubMed ID: 17077079
[TBL] [Abstract][Full Text] [Related]
35. Intestinal microbiota, pathophysiology and translation to probiotic use in patients with irritable bowel syndrome.
Almansa C; Agrawal A; Houghton LA
Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):383-98. PubMed ID: 22646259
[TBL] [Abstract][Full Text] [Related]
36. Functions of intestinal microflora in children.
Buccigrossi V; Nicastro E; Guarino A
Curr Opin Gastroenterol; 2013 Jan; 29(1):31-8. PubMed ID: 23196853
[TBL] [Abstract][Full Text] [Related]
37. Effects of Enterococcus faecium NCIMB 10415 as probiotic supplement on intestinal transport and barrier function of piglets.
Lodemann U; Hübener K; Jansen N; Martens H
Arch Anim Nutr; 2006 Feb; 60(1):35-48. PubMed ID: 16529156
[TBL] [Abstract][Full Text] [Related]
38. Probiotics and gastrointestinal diseases.
Sullivan A; Nord CE
J Intern Med; 2005 Jan; 257(1):78-92. PubMed ID: 15606379
[TBL] [Abstract][Full Text] [Related]
39. [What we gained from a century of investigations of symbiontic intestinal microflora].
Ter Arkh; 2012; 84(2):5-10. PubMed ID: 22715654
[TBL] [Abstract][Full Text] [Related]
40. [Problem of the choice of the probiotic dose in the physician practice].
Gonchar NV; Suvorov AN; Fedorova MS
Eksp Klin Gastroenterol; 2014; (1):46-52. PubMed ID: 25518457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
